These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17537855)

  • 1. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
    Lavillette D; Pécheur EI; Donot P; Fresquet J; Molle J; Corbau R; Dreux M; Penin F; Cosset FL
    J Virol; 2007 Aug; 81(16):8752-65. PubMed ID: 17537855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry.
    Ciczora Y; Callens N; Penin F; Pécheur EI; Dubuisson J
    J Virol; 2007 Mar; 81(5):2372-81. PubMed ID: 17166909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
    Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
    Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
    Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
    Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry.
    Rothwangl KB; Rong L
    Virol J; 2009 Jan; 6():12. PubMed ID: 19171049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2.
    Albecka A; Montserret R; Krey T; Tarr AW; Diesis E; Ball JK; Descamps V; Duverlie G; Rey F; Penin F; Dubuisson J
    J Virol; 2011 Feb; 85(4):1777-92. PubMed ID: 21147916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.
    Russell RS; Kawaguchi K; Meunier JC; Takikawa S; Faulk K; Bukh J; Purcell RH; Emerson SU
    J Viral Hepat; 2009 Sep; 16(9):621-32. PubMed ID: 19302336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
    Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
    Drummer HE; Boo I; Maerz AL; Poumbourios P
    J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV envelope protein function is dependent on the peptides preceding the glycoproteins.
    Bian T; Zhou Y; Bi S; Tan W; Wang Y
    Biochem Biophys Res Commun; 2009 Jan; 378(1):118-22. PubMed ID: 19013428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional hepatitis C virus envelope glycoproteins.
    Voisset C; Dubuisson J
    Biol Cell; 2004 Aug; 96(6):413-20. PubMed ID: 15325070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.
    Boo I; teWierik K; Douam F; Lavillette D; Poumbourios P; Drummer HE
    Biochem J; 2012 Apr; 443(1):85-94. PubMed ID: 22240035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions.
    Keck ZY; Op De Beeck A; Hadlock KG; Xia J; Li TK; Dubuisson J; Foung SK
    J Virol; 2004 Sep; 78(17):9224-32. PubMed ID: 15308717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
    Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pseudotype VSV possessing HCV envelope proteins.
    Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
    Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins.
    Pérez-Berna AJ; Moreno MR; Guillén J; Bernabeu A; Villalaín J
    Biochemistry; 2006 Mar; 45(11):3755-68. PubMed ID: 16533059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
    Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
    J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes.
    Lavillette D; Bartosch B; Nourrisson D; Verney G; Cosset FL; Penin F; Pécheur EI
    J Biol Chem; 2006 Feb; 281(7):3909-17. PubMed ID: 16356932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.
    Bartosch B; Verney G; Dreux M; Donot P; Morice Y; Penin F; Pawlotsky JM; Lavillette D; Cosset FL
    J Virol; 2005 Jul; 79(13):8217-29. PubMed ID: 15956567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.